<SEC-DOCUMENT>0001009448-18-000001.txt : 20180410
<SEC-HEADER>0001009448-18-000001.hdr.sgml : 20180410
<ACCEPTANCE-DATETIME>20180410125025
ACCESSION NUMBER:		0001009448-18-000001
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		<ITEMS>06b
FILED AS OF DATE:		20180410
DATE AS OF CHANGE:		20180410
EFFECTIVENESS DATE:		20180410

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BriaCell Therapeutics Corp.
		CENTRAL INDEX KEY:			0001610820
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0731

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-309749
		FILM NUMBER:		18747471

	BUSINESS ADDRESS:	
		STREET 1:		3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
		CITY:			WEST VANCOUVER
		STATE:			A1
		ZIP:			V7T 2X1
		BUSINESS PHONE:		(604) 921-1810

	MAIL ADDRESS:	
		STREET 1:		3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
		CITY:			WEST VANCOUVER
		STATE:			A1
		ZIP:			V7T 2X1

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Ansell Capital Corp.
		DATE OF NAME CHANGE:	20140613
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0708</schemaVersion>

    <submissionType>D</submissionType>

    <testOrLive>LIVE</testOrLive>

    <primaryIssuer>
        <cik>0001610820</cik>
        <entityName>BriaCell Therapeutics Corp.</entityName>
        <issuerAddress>
            <street1>SUITE 300, BELLEVUE CENTRE, 235-15TH STR</street1>
            <city>WEST VANCOUVER</city>
            <stateOrCountry>A1</stateOrCountry>
            <stateOrCountryDescription>BRITISH COLUMBIA, CANADA</stateOrCountryDescription>
            <zipCode>V7T 2X1</zipCode>
        </issuerAddress>
        <issuerPhoneNumber>(604) 921-1810</issuerPhoneNumber>
        <jurisdictionOfInc>BRITISH COLUMBIA, CANADA</jurisdictionOfInc>
        <edgarPreviousNameList>
            <previousName>Ansell Capital Corp.</previousName>
        </edgarPreviousNameList>
        <entityType>Corporation</entityType>
        <yearOfInc>
            <overFiveYears>true</overFiveYears>
        </yearOfInc>
    </primaryIssuer>

    <relatedPersonsList>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Charles</firstName>
                <lastName>Wiseman</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>Suite 300, Bellevue Center</street1>
                <street2>235-15th Street</street2>
                <city>West Vancouver</city>
                <stateOrCountry>A1</stateOrCountry>
                <stateOrCountryDescription>BRITISH COLUMBIA, CANADA</stateOrCountryDescription>
                <zipCode>V7T 2X1</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Saeid</firstName>
                <lastName>Babaei</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>Suite 300, Bellevue Center</street1>
                <street2>235-15th Street</street2>
                <city>West Vancouver</city>
                <stateOrCountry>A1</stateOrCountry>
                <stateOrCountryDescription>BRITISH COLUMBIA, CANADA</stateOrCountryDescription>
                <zipCode>V7T 2X1</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>William</firstName>
                <middleName>V.</middleName>
                <lastName>Williams</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>Suite 300, Bellevue Center</street1>
                <street2>235-15th Street</street2>
                <city>West Vancouver</city>
                <stateOrCountry>A1</stateOrCountry>
                <stateOrCountryDescription>BRITISH COLUMBIA, CANADA</stateOrCountryDescription>
                <zipCode>V7T 2X1</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification>President &amp; Chief Executive Officer</relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Martin</firstName>
                <lastName>Schmieg</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>Suite 300, Bellevue Center</street1>
                <street2>235-15th Street</street2>
                <city>West Vancouver</city>
                <stateOrCountry>A1</stateOrCountry>
                <stateOrCountryDescription>BRITISH COLUMBIA, CANADA</stateOrCountryDescription>
                <zipCode>V7T 2X1</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Gadi</firstName>
                <lastName>Levin</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>Suite 300, Bellevue Centre</street1>
                <street2>235-15th Street</street2>
                <city>West Vancouver</city>
                <stateOrCountry>A1</stateOrCountry>
                <stateOrCountryDescription>BRITISH COLUMBIA, CANADA</stateOrCountryDescription>
                <zipCode>V7T 2X1</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification>Chief Financial Officer and Corporate Secretary</relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Rahoul</firstName>
                <lastName>Sharan</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>Suite 300, Bellevue Center</street1>
                <street2>235-15th Street</street2>
                <city>West Vancouver</city>
                <stateOrCountry>A1</stateOrCountry>
                <stateOrCountryDescription>BRITISH COLUMBIA, CANADA</stateOrCountryDescription>
                <zipCode>V7T 2X1</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
    </relatedPersonsList>

    <offeringData>
        <industryGroup>
            <industryGroupType>Biotechnology</industryGroupType>
        </industryGroup>
        <issuerSize>
            <revenueRange>Decline to Disclose</revenueRange>
        </issuerSize>
        <federalExemptionsExclusions>
            <item>06b</item>
        </federalExemptionsExclusions>
        <typeOfFiling>
            <newOrAmendment>
                <isAmendment>false</isAmendment>
            </newOrAmendment>
            <dateOfFirstSale>
                <value>2018-03-27</value>
            </dateOfFirstSale>
        </typeOfFiling>
        <durationOfOffering>
            <moreThanOneYear>false</moreThanOneYear>
        </durationOfOffering>
        <typesOfSecuritiesOffered>
            <isDebtType>true</isDebtType>
            <isOptionToAcquireType>true</isOptionToAcquireType>
            <isSecurityToBeAcquiredType>true</isSecurityToBeAcquiredType>
        </typesOfSecuritiesOffered>
        <businessCombinationTransaction>
            <isBusinessCombinationTransaction>false</isBusinessCombinationTransaction>
            <clarificationOfResponse></clarificationOfResponse>
        </businessCombinationTransaction>
        <minimumInvestmentAccepted>0</minimumInvestmentAccepted>
        <salesCompensationList>
            <recipient>
                <recipientName>Newbridge Securities Corporation (LifeTech Capital division)</recipientName>
                <recipientCRDNumber>104065</recipientCRDNumber>
                <associatedBDName>None</associatedBDName>
                <associatedBDCRDNumber>None</associatedBDCRDNumber>
                <recipientAddress>
                    <street1>5200 Town Center Circle</street1>
                    <street2>Tower 1, Suite 306</street2>
                    <city>Boca Raton</city>
                    <stateOrCountry>FL</stateOrCountry>
                    <stateOrCountryDescription>FLORIDA</stateOrCountryDescription>
                    <zipCode>33486</zipCode>
                </recipientAddress>
                <statesOfSolicitationList>
                    <state>NJ</state>
                    <description>NEW JERSEY</description>
                    <state>NY</state>
                    <description>NEW YORK</description>
                </statesOfSolicitationList>
                <foreignSolicitation>true</foreignSolicitation>
            </recipient>
        </salesCompensationList>
        <offeringSalesAmounts>
            <totalOfferingAmount>800000</totalOfferingAmount>
            <totalAmountSold>800000</totalAmountSold>
            <totalRemaining>0</totalRemaining>
            <clarificationOfResponse></clarificationOfResponse>
        </offeringSalesAmounts>
        <investors>
            <hasNonAccreditedInvestors>false</hasNonAccreditedInvestors>
            <totalNumberAlreadyInvested>3</totalNumberAlreadyInvested>
        </investors>
        <salesCommissionsFindersFees>
            <salesCommissions>
                <dollarAmount>64000</dollarAmount>
            </salesCommissions>
            <findersFees>
                <dollarAmount>0</dollarAmount>
            </findersFees>
            <clarificationOfResponse>The above figure does not include the grant of a warrant fee equal to 8% of all notes converted, payable to Newbridge Securities Corporation upon conversion.</clarificationOfResponse>
        </salesCommissionsFindersFees>
        <useOfProceeds>
            <grossProceedsUsed>
                <dollarAmount>0</dollarAmount>
            </grossProceedsUsed>
            <clarificationOfResponse></clarificationOfResponse>
        </useOfProceeds>
        <signatureBlock>
            <authorizedRepresentative>false</authorizedRepresentative>
            <signature>
                <issuerName>BriaCell Therapeutics Corp.</issuerName>
                <signatureName>William Williams</signatureName>
                <nameOfSigner>Dr. William V. Williams</nameOfSigner>
                <signatureTitle>President &amp; Chief Executive Officer</signatureTitle>
                <signatureDate>2018-04-09</signatureDate>
            </signature>
        </signatureBlock>
    </offeringData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
